By VeloNews Interactive
The UCI announced Thursday that it will unveil a new drug to detect EPO (erythropoietin) on Friday. According to a report by AFP, the new test will employ both blood and urine sample testing, and will first be used at the Tour of Flanders World Cup race on April 8. UCI president Hein Verbruggen announced in December that the problem of finding an acceptable test for cyclists would be “resolved before April.”
EPO has, until now, been relatively undetectable. Under current procedures, a rider who exceeds the hematocrit (red blood cell) threshold of 50 is given a 15-day “warning” in order to resolve the problem of his elevated hematocrit level. The aim of the new test is to detect EPO, and riders who test positive will face harsher disciplinary action.